<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01010490</url>
  </required_header>
  <id_info>
    <org_study_id>07-009</org_study_id>
    <nct_id>NCT01010490</nct_id>
  </id_info>
  <brief_title>Outcomes of Phacoemulsification With Torsional Ultrasound</brief_title>
  <official_title>A Randomised Trial of Torsional Ultrasound Versus Longitudinal Ultrasound During Phacoemulsification of Age-related Cataracts: Comparison of Intra-operative Performance and Impact on Post-operative Endothelium Integrity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Iladevi Cataract and IOL Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Iladevi Cataract and IOL Research Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the differences in intra-operative complications, surgical duration, fluid
      usage, corneal thickness and endothelium cell density in eyes undergoing microcoaxial
      phacoemulsification (MCP) either with Torsional or longitudinal ultrasound during the surgery
      and at post-operative day 1, 1 month and 3 months.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduced in mid 2006, torsional ultrasound (OZil, Infiniti Vision System, Alcon
      Laboratories, Texas, USA) uses rotational oscillations at ultrasonic frequencies to emulsify
      cataractous lens material in a seamless cutting motion from a tip that oscillates laterally.
      The side-to-side movement of the phaco tip produces minimal repulsion of lens material from
      the phaco tip resulting in improved followability. Clinically this translates into more
      effective lens removal with torsional phaco in comparison to the conventional ultrasound
      mode.to test this in a clinical scenario we undertook this study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intra-operative complications, surgical clock time in minutes (SCT), fluid volume in ml(FV), and central corneal thickness in Âµm (CCT) on day 1 and months 1 and 3, and endothelial cell density (ECD) at 3 months.</measure>
    <time_frame>3 months post-operative</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">360</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Torsional ultrasound</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Torsional ultrasound with the INFINITI phacoemulsification system (Alcon Lab, USA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Longitudinal ultrasound (INFINITI)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Longitudinal ultrasound with the INFINITI phacomachine (Alcon Lab, USA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Longitudinal ultrasound (LEGACY)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Longitudinal ultrasound with the LEGACY phacomachine (Alcon Lab, USA)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Torsional ultrasound (INFINITI, Alcon, USA)</intervention_name>
    <description>Comparison of inta-operative efficacy and safety</description>
    <arm_group_label>Torsional ultrasound</arm_group_label>
    <other_name>OZIL technology</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Longitudinal U/S (Infiniti system, Alcon, USA)</intervention_name>
    <description>comparison of efficacy and safety</description>
    <arm_group_label>Longitudinal ultrasound (INFINITI)</arm_group_label>
    <other_name>traditional ultrasound</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Longitudinal U/S (LEGACY 20000, Alcon, USA)</intervention_name>
    <description>Interrupted energy modality</description>
    <arm_group_label>Longitudinal ultrasound (LEGACY)</arm_group_label>
    <other_name>Traditional U/S</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients 55 years and older with a senile cataract grades 1 to 5 nuclear sclerosis
             based on Emery's classification,

          -  endothelial cell density &gt; 1500 cells/mm2,

          -  anterior chamber depth &gt; 2.4 mm, and

          -  a dilated pupil &gt; 7 mm.

        Exclusion Criteria:

          -  eyes with pseudoexfoliation,

          -  mature, traumatic, or complicated cataracts,

          -  history of previous intra-ocular surgery, glaucoma, uveitis, and

          -  patients who were unable to comply with follow-up examinations.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>shetal m raj, ms</last_name>
    <role>Principal Investigator</role>
    <affiliation>Iladevi Cataract and IOL Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Raghudeep eye clinic</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <zip>52</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <results_reference>
    <citation>Liu Y, Zeng M, Liu X, Luo L, Yuan Z, Xia Y, Zeng Y. Torsional mode versus conventional ultrasound mode phacoemulsification: randomized comparative clinical study. J Cataract Refract Surg. 2007 Feb;33(2):287-92.</citation>
    <PMID>17276271</PMID>
  </results_reference>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 9, 2009</study_first_submitted>
  <study_first_submitted_qc>November 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2009</study_first_posted>
  <last_update_submitted>November 11, 2009</last_update_submitted>
  <last_update_submitted_qc>November 11, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 13, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. Shetal Raj</name_title>
    <organization>Raghudeep eye clinic</organization>
  </responsible_party>
  <keyword>PACHYMETRY</keyword>
  <keyword>CELL LOSS</keyword>
  <keyword>SAFETY</keyword>
  <keyword>EFFICACY</keyword>
  <keyword>PHACOEMULSIFICATION</keyword>
  <keyword>Intraoperative complications</keyword>
  <keyword>CLOCK TIME</keyword>
  <keyword>FLUID USED</keyword>
  <keyword>CORNEAL THICKNESS</keyword>
  <keyword>ENDOTHELIUM CELL LOSS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dipivefrin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

